NLRP3 inhibition was associated with reduced colitis severity and histological damage of colonic mucosa, supporting that PGA exerts an anti-inflammatory effect by suppressing NLRP3 activity through PPAR-α receptor involvement. The gene discussed is NLRP3; the disease is colitis.